FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386860320> ?p ?o ?g. }

• W4386860320 endingPage "OF7" @default.
• W4386860320 startingPage "OF1" @default.
• W4386860320 abstract "Abstract Purpose: The GeparX study investigated whether denosumab as add-on treatment to nab-paclitaxel–based neoadjuvant chemotherapy (NACT) with two different schedules (125 mg/m² weekly vs. day 1, 8 every 22 days) may increase pathologic complete response (pCR) rate. The addition of denosumab to NACT did not improve pCR rates as recently published. In this study, we investigated whether receptor activator of nuclear factor-kappa B (RANK) expression, as part of the denosumab target pathway: (i) may retrospectively identify a subgroup of patients with additional clinical benefit of denosumab or (ii) may predict response to nab-paclitaxel NACT. Experimental Design: RANK protein was IHC-stained on pre-therapeutic core biopsies from patients of the GeparX study (n = 667) with the antibody RANK/Envision System HRP (DAB) and was analyzed for the percentage of membranous RANK tumor cell staining (&gt;5% RANKhigh vs. ≤5% RANKlow). Results: We could not identify any patient subgroup with differential response under denosumab add-on treatment in patients with RANKhigh expression [139/667, 20.8%; OR, 0.86; 95% confidence interval (CI), 0.44–1.68; P = 0.667] or RANKlow expression (528/667 (79.2%) OR, 1.10; 95% CI, 0.78–1.56; P = 0.589; Pinteraction = 0.528). However, the pCR rate was higher in the RANKhigh subgroup compared with RANKlow (50% vs. 39%; OR, 1.52; 95% CI, 1.04–2.21; P = 0.037). RANK expression constituted an independent predictor of response to NACT frequently in patients with luminal-like subtype (HR+/HER2−; OR, 2.98; 95% CI, 1.30–6.79; P = 0.010). No predictive value of RANK expression among the different nab-paclitaxel regimens was observed. Conclusion: We report RANK expression to be an independent predictive biomarker for response to NACT in patients with luminal-like breast cancer." @default.
• W4386860320 created "2023-09-20" @default.
• W4386860320 creator A5002071285 @default.
• W4386860320 creator A5003405177 @default.
• W4386860320 creator A5007997038 @default.
• W4386860320 creator A5010971321 @default.
• W4386860320 creator A5011672118 @default.
• W4386860320 creator A5016987068 @default.
• W4386860320 creator A5017728105 @default.
• W4386860320 creator A5024469109 @default.
• W4386860320 creator A5024741688 @default.
• W4386860320 creator A5032374221 @default.
• W4386860320 creator A5033698551 @default.
• W4386860320 creator A5040227537 @default.
• W4386860320 creator A5050467390 @default.
• W4386860320 creator A5052578346 @default.
• W4386860320 creator A5055059973 @default.
• W4386860320 creator A5055136263 @default.
• W4386860320 creator A5057181684 @default.
• W4386860320 creator A5067146231 @default.
• W4386860320 creator A5084924207 @default.
• W4386860320 creator A5087559224 @default.
• W4386860320 creator A5089392438 @default.
• W4386860320 date "2023-10-05" @default.
• W4386860320 modified "2023-10-07" @default.
• W4386860320 title "RANK expression as an independent predictor for response to neoadjuvant chemotherapy in luminal-like breast cancer - a translational insight from the GeparX trial" @default.
• W4386860320 doi "https://doi.org/10.1158/1078-0432.ccr-23-1801" @default.
• W4386860320 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37725572" @default.
• W4386860320 hasPublicationYear "2023" @default.
• W4386860320 type Work @default.
• W4386860320 citedByCount "0" @default.
• W4386860320 crossrefType "journal-article" @default.
• W4386860320 hasAuthorship W4386860320A5002071285 @default.
• W4386860320 hasAuthorship W4386860320A5003405177 @default.
• W4386860320 hasAuthorship W4386860320A5007997038 @default.
• W4386860320 hasAuthorship W4386860320A5010971321 @default.
• W4386860320 hasAuthorship W4386860320A5011672118 @default.
• W4386860320 hasAuthorship W4386860320A5016987068 @default.
• W4386860320 hasAuthorship W4386860320A5017728105 @default.
• W4386860320 hasAuthorship W4386860320A5024469109 @default.
• W4386860320 hasAuthorship W4386860320A5024741688 @default.
• W4386860320 hasAuthorship W4386860320A5032374221 @default.
• W4386860320 hasAuthorship W4386860320A5033698551 @default.
• W4386860320 hasAuthorship W4386860320A5040227537 @default.
• W4386860320 hasAuthorship W4386860320A5050467390 @default.
• W4386860320 hasAuthorship W4386860320A5052578346 @default.
• W4386860320 hasAuthorship W4386860320A5055059973 @default.
• W4386860320 hasAuthorship W4386860320A5055136263 @default.
• W4386860320 hasAuthorship W4386860320A5057181684 @default.
• W4386860320 hasAuthorship W4386860320A5067146231 @default.
• W4386860320 hasAuthorship W4386860320A5084924207 @default.
• W4386860320 hasAuthorship W4386860320A5087559224 @default.
• W4386860320 hasAuthorship W4386860320A5089392438 @default.
• W4386860320 hasConcept C10515644 @default.
• W4386860320 hasConcept C121608353 @default.
• W4386860320 hasConcept C126322002 @default.
• W4386860320 hasConcept C143998085 @default.
• W4386860320 hasConcept C187960798 @default.
• W4386860320 hasConcept C204232928 @default.
• W4386860320 hasConcept C2776286101 @default.
• W4386860320 hasConcept C2776541429 @default.
• W4386860320 hasConcept C2776694085 @default.
• W4386860320 hasConcept C2777292972 @default.
• W4386860320 hasConcept C2778292576 @default.
• W4386860320 hasConcept C44249647 @default.
• W4386860320 hasConcept C530470458 @default.
• W4386860320 hasConcept C66339696 @default.
• W4386860320 hasConcept C71924100 @default.
• W4386860320 hasConceptScore W4386860320C10515644 @default.
• W4386860320 hasConceptScore W4386860320C121608353 @default.
• W4386860320 hasConceptScore W4386860320C126322002 @default.
• W4386860320 hasConceptScore W4386860320C143998085 @default.
• W4386860320 hasConceptScore W4386860320C187960798 @default.
• W4386860320 hasConceptScore W4386860320C204232928 @default.
• W4386860320 hasConceptScore W4386860320C2776286101 @default.
• W4386860320 hasConceptScore W4386860320C2776541429 @default.
• W4386860320 hasConceptScore W4386860320C2776694085 @default.
• W4386860320 hasConceptScore W4386860320C2777292972 @default.
• W4386860320 hasConceptScore W4386860320C2778292576 @default.
• W4386860320 hasConceptScore W4386860320C44249647 @default.
• W4386860320 hasConceptScore W4386860320C530470458 @default.
• W4386860320 hasConceptScore W4386860320C66339696 @default.
• W4386860320 hasConceptScore W4386860320C71924100 @default.
• W4386860320 hasLocation W43868603201 @default.
• W4386860320 hasLocation W43868603202 @default.
• W4386860320 hasOpenAccess W4386860320 @default.
• W4386860320 hasPrimaryLocation W43868603201 @default.
• W4386860320 hasRelatedWork W1996943007 @default.
• W4386860320 hasRelatedWork W2065962239 @default.
• W4386860320 hasRelatedWork W2075069343 @default.
• W4386860320 hasRelatedWork W2508842317 @default.
• W4386860320 hasRelatedWork W2943676592 @default.
• W4386860320 hasRelatedWork W2951955041 @default.
• W4386860320 hasRelatedWork W3017270174 @default.
• W4386860320 hasRelatedWork W4248326559 @default.
• W4386860320 hasRelatedWork W4249801873 @default.
• W4386860320 hasRelatedWork W4252947151 @default.
• W4386860320 isParatext "false" @default.

• next